IX Division and Biomechanics Laboratory, Rizzoli Orthopaedic Institute, Via Di Barbiano, 1/10, 40136 Bologna, Italy.
Injury. 2010 Jul;41(7):693-701. doi: 10.1016/j.injury.2009.11.014. Epub 2009 Dec 24.
Osteochondral articular defects are a key concern in orthopaedic surgery. Current surgical techniques to repair osteochondral defects lead to poor subchondral bone regeneration and fibrocartilage formation, which is often associated with joint pain and stiffness. The objective of this pilot clinical study is to evaluate the performance and the intrinsic stability of a newly developed biomimetic osteochondral scaffold and to test the safety and the feasibility of the surgical procedure.
A gradient composite osteochondral scaffold based on type I collagen-hydroxyapatite was obtained by nucleating collagen fibrils with hydroxyapatite nanoparticles. Thirteen patients (15 defect sites) were treated with scaffold implantation from January 2007 to July 2007: four at the medial femoral condyle, two at the lateral femoral condyles, five at the patellas and four at the trochleas. The mean size of the defects was 2.8 cm(2) (range: 1.5-5.9 cm(2)). All patients were followed up prospectively. High-resolution magnetic resonance imaging (MRI) was used to determine "the early postoperative adherence rate" at 4-5 weeks and 25-26 weeks after scaffold implantation. Moreover, the magnetic resonance observation of cartilage repair tissue (MOCART) score was performed on every MRI. Two second-looks were performed at 6 months; cartilage repair was assessed using the International Cartilage Repair Society (ICRS) visual scoring system and histological and immunohistochemical analysis of the two biopsies was carried out.
A completely attached graft and repair tissue were found in 13 of 15 lesions (86.7%). A partial detachment was observed in two patients (13.3%). No detached grafts were found. Complete filling of the cartilage defect and congruency of the articular surface were seen in 10 lesions (66.7%) with MRI evaluation at 6 months. The complete integration of the grafted cartilage was detected in eight lesions (53.3%). Subchondral bone changes (oedema or sclerosis) were found in eight defects (53.3%). Statistical analysis showed a significant improvement in the International Knee Documentation Committee (IKDC) subjective and objective scores from preoperative to 6 months' follow-up (p<0.0005). Visual scoring of the repaired tissue at second-look revealed a normal repair score in one case and a near-normal repair score in the other case. Histological analysis showed the formation of subchondral bone without the presence of biomaterial. The cartilage repair tissue appeared to be engaged in an ongoing maturation process.
The technique is safe and MRI evaluation at short-term follow-up has demonstrated good stability of the scaffold without any other fixation device. The preliminary clinical results at short-term follow-up are encouraging. A clinical and MRI study with longer follow-up and randomised studies will be done to confirm the high potential of this novel osteochondral scaffold.
骨软骨关节缺损是矫形外科的一个关键关注点。目前用于修复骨软骨缺损的手术技术导致软骨下骨再生和纤维软骨形成不良,这通常与关节疼痛和僵硬有关。本初步临床研究的目的是评估一种新开发的仿生骨软骨支架的性能和内在稳定性,并测试手术的安全性和可行性。
通过将纳米羟基磷灰石核化胶原纤维,获得基于 I 型胶原-羟基磷灰石的梯度复合骨软骨支架。2007 年 1 月至 2007 年 7 月,13 名患者(15 个缺损部位)接受了支架植入治疗:股骨内侧髁 4 例,股骨外侧髁 2 例,髌骨 5 例,滑车 4 例。缺损的平均大小为 2.8cm²(范围:1.5-5.9cm²)。所有患者均进行前瞻性随访。高分辨率磁共振成像(MRI)用于在支架植入后 4-5 周和 25-26 周时确定“术后早期粘附率”。此外,对每例 MRI 进行磁共振软骨修复组织(MOCART)评分。在 6 个月时进行了两次复诊;使用国际软骨修复协会(ICRS)视觉评分系统评估软骨修复,并对两次活检进行组织学和免疫组织化学分析。
15 个病变中有 13 个(86.7%)完全附着的移植物和修复组织。两名患者(13.3%)观察到部分分离。未发现移植物脱落。在 6 个月的 MRI 评估中,10 个病变(66.7%)中可见完全填充的软骨缺损和关节表面的一致性。在 8 个病变(53.3%)中检测到移植物软骨的完全整合。在 8 个病变(53.3%)中发现软骨下骨改变(水肿或硬化)。统计学分析显示,国际膝关节文献委员会(IKDC)主观和客观评分从术前到 6 个月随访时均有显著改善(p<0.0005)。在第二次就诊时,对修复组织的视觉评分显示 1 例为正常修复评分,1 例为接近正常修复评分。组织学分析显示形成了软骨下骨,没有生物材料的存在。软骨修复组织似乎处于持续成熟过程中。
该技术是安全的,短期随访的 MRI 评估表明支架具有良好的稳定性,无需任何其他固定装置。短期随访的初步临床结果令人鼓舞。将进行更长时间随访和随机研究的临床和 MRI 研究,以确认这种新型骨软骨支架的高潜力。